Introduction
We are doctors looking after patients with blood disorders and scientists studying blood conditions in the lab. Our aim is to deliver the best expert and compassionate care for patients with blood diseases and patients who need blood cell transfusions. We want to reduce the burden of disease now and in the future, through our research, services, education, outreach and advocacy.
Our group includes international, scientific and clinical leaders. We draw on our combined expertise to carry out research and develop new services. Through our work we aim to:
- Improve the cost-effectiveness of cancer therapies and the outcomes of treatment – by developing new single cell approaches which tailor treatments to individuals. Find out more
- Improve the management of common and rare anaemias – by studying the role of iron and inflammation in anaemic patients, especially those who are elderly, and by developing a new national NHS service for patients with rare inherited red cell disorders. Find out more
- Improve the outcomes of blood cell and blood component transfusions – by using advanced e-tools and carrying out clinical trials to find out what approaches work best. Find out more
- Involve patients and carers in the key steps of our research projects. Find out more
Related websites
Oxford Centre for Haematology website: rdm.ox.ac.uk/och
RDM – HaemBio Biobank pages:
rdm.ox.ac.uk/about/our-clinical-facilities-and-mrc-units/och/haembio
NSSG website: nssg.oxford-haematology.org.uk
Introductory Talk by Haematology and Stem Cells Theme Lead Professor Paresh Vyas
Follow the Oxford Centre for Haematology on Twitter
Erythroblasts enucleating their way through Valentine’s Day ❣️
"Things I’ve found more uncomfortable than donating stem cells:
1. Bikini wax 👙
2. Post bottomless brunch hangover 🥂
3. First gym session after Christmas 💪
4. Breaking in new shoes 👠
5. PMS pains 😩
6. Rush hour commute 🚇
7. Being near blue cheese 🧀"
- Ellice, DKMS donor
New from Stem Cell Evidence our top article this month is Walker et al in @TheLancetHaem Addition of ATG to standard #GvHD prophylaxis in patients with haem-malignancy undergoing transplant from unrelated donors https://t.co/5gAcdO1MY8
I am wondering if there is currently any research being undertaken in the UK on the prevelance of Leukaemia Cutis as a presentation of AML? I am a lay person, but have a personal interest. Thankyou. @BritSocHaem @OxfordHaem @CRGHaem @LeukaemiaCareUK @LeukUK @bloodwise_uk
Happy Women in Science Day! #WomenInScienceDay #WomenInSTEM
More of our women in Haematology in the @MRC_WIMM in @RDMOxford #WomenInScience